8 news items
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy
MAIA
7 Jun 24
role of telomere targeting as a viable therapeutic strategy for cancer treatment
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA
6 Jun 24
to a minimum. We plan to continue this strategy, which has shown desired outcomes so far this year while our share price has more than tripled," added Dr
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
CORT
HALO
MAIA
6 Jun 24
or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully read and comprehend our disclaimer found
Treatment.com AI's (CSE: TRUE) Strategic Partnership with Novus Health, New Board Appointment, and Major Contract To Revolutionize Healthcare, Driving Momentum in the Industry
CBAT
MAIA
NTRB
4 Jun 24
a wealth of experience in health technology and business strategy, is expected to play a pivotal role in steering the company towards new heights
z15 uwarmdg199dv
AFMD
ALBT
BPTH
4 Jun 24
strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully read and comprehend our disclaimer found
hdpdhyfpoiecgw bi58szshcb89lsotild78b2q76
CRL
IQV
MAIA
31 May 24
is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES
z7ety 9l7
ABBV
JNJ
LLY
21 May 24
purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY
- Prev
- 1
- Next